New Key Statistics Module, Z-Score and F-Score
NAS:ARCT Key Ratios
| Market Cap $ M | 504.91 |
| Enterprise Value $ M | 289.03 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.93 |
| Price/Sales | 3.52 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 142.00 |
| EPS (TTM) $ | -2.22 |
| Beneish M-Score | -2.93 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -119.60 |
| EV-to-EBIT | -13.29 |
| EV-to-EBITDA | -15.88 |
| PEG | -- |
| Shares Outstanding M | 27.09 |
| Net Margin (%) | -43.97 |
| Operating Margin % | -56.54 |
| Pre-tax Margin (%) | -43.79 |
| Quick Ratio | 4.76 |
| Current Ratio | 4.76 |
| ROA % (ttm) | -15.17 |
| ROE % (ttm) | -23.32 |
| ROIC % (ttm) | -70.73 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.83 |
ARCT Number of Guru Trades
ARCT Volume of Guru Trades
Gurus Latest Trades with NAS:ARCT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ARCT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Arcturus Therapeutics Holdings Inc Insider Transactions
No Available Data
News about NAS:ARCT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers